Accuray Inc. - ARAY Operating Margin

Public company logo of Accuray Incorporated (ARAY)

The expansion of the CyberKnife network and the implementation of AI planning are driving growth, forcing Accuray Incorporated (ARAY) to flexibly adjust pricing to win tenders. The operating profit margin clearly demonstrates this dependency, where the -0.60 indicator determines the magnitude of the metric. Financial stability is further bolstered by the delivery of robotic systems to major medical centers, through which the company generates revenue from high-precision treatment.

ARAY - Accuray Inc Operating Return on Sales over the range 07/04/2022 - 11/19/2026

ARAY (accuray.com): analytical breakdowns and indicator data

- price and consensus price forecast:
General company analysis:Accuray, Inc., ARAY
Finished products of Accuray Incorporated

Accuray Incorporated specializes in developing high-tech robotic systems for precision radiation therapy. Operating margin measures the efficiency of the core business, reflecting the share of profit before taxes and interest obligations in total revenue. For an investor, this metric serves as an indicator of the company's ability to monetize R&D investments in AI algorithms. Analyzing the current operating margin value on GURU.Markets allows for an assessment of the balance between innovative development and operational profitability. The trend of this indicator reveals risks or the potential for growth in the business's market capitalization.

Analysis of competing companies

Operating Profitability BeiGene Ltd|Halozyme Therapeutics - Operating Profit Margin|Operating Sales Margin RVMD (Revolution Medicines Corp)|Operating Profit Ratio AAPG|Operating Profitability CG Oncology Therapeutics CGON|Operating Profit Rate URGN|BCAX: Operating Sales Margin|PSNL: Operating Profitability|Erasca (ERAS) - Operating Profitability|DCTH - Profitability of Operations|YMAB (Y-mAbs Corp) - Operating Margin|Operating Sales Margin Aura Biosciences (AURA)|Operating Profitability Candel Therapeutics Inc. (CADL)|SLS (SELLAS Life Sciences Group, Inc.) - Operating Profit Rate|Operating Profitability Actuate Therapeutics, Inc. ACTU|citiusonc.com - Operating Profitability|TuHURA Biosciences Inc. - Operating Margin|TARA - Operating Margin|FATE (Fate Therapeutics) - Operating Sales Margin|Operating Sales Margin Aadi Bioscience, Inc.|Operating Sales Margin TCRX|Operating Profitability CSBR|Operating Margin XBIT|Profitability of Operations CEL-SCI Corp.|Operating Profitability ostherapies.com OSTX|RADX: Return on Sales by Operating Profit|ARTV: Operating Sales Margin|ANL (Adlai Nortye) - Return on Sales by Operating Profit|Veru (VERU) - Operating Profitability|Operating Sales Margin Tempest Therapeutics Inc|Operating Profitability Xilio Therapeutics|Return on Sales by Operating Profit RENB (Renovaro Inc.)|Operating Profitability Mural Oncology PLC (MURA)|Operating Margin Kairos Pharma (KAPA)|Operating Profitability onkuretherapeutics.com OKUR|GDTC: Return on Sales by Operating Profit|CRIS: Operating Sales Margin|apollomicsinc.com (APLM) - Operating Sales Margin|THAR: Operating Margin|Operating Sales Margin Advanced Biomed Inc.|Operating Sales Margin GNPX|Return on Sales by Operating Profit CLDI (Calidi Biotherapeutics)|Operating Margin SBFM|Xenetic Biosciences, Inc. - Return on Sales by Operating Profit|Operating Profitability Salarius Pharmaceuticals SLRX|Operating Margin purple-biotech.com PPBT|AONC - Operating Profitability|BGNE: Operating Profitability|CKPT: Operating Margin|Elevation Oncology - Operating Profit Rate|ICAD (iCAD) - Operating Margin|IKNA: Operating Profit Rate|Operating Profitability Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operating Profit Rate|Operating Profitability MorphoSys Corporation MOR|NAYA: Return on Sales by Operating Profit|Ascentage Pharma Group International - Operating Margin